Heinz Riesenhuber

Frankfurter Allgemeine Zeitung GmbH engages in the publication and distribution of daily newspapers, business papers, and books. It also offers an electronic newspaper, which can be accessed via a mobile application. The company was founded in November 1949 and is headquartered in Frankfurt, Germany.

Vodafone Holding GmbH provides mobile telecommunications services such as voice and data communications. It operates a digital network based on the GSM standard. The company is headquartered in Dusseldorf, Germany.

Vfw AG provides logistic, supply chain management and E-Commerce solutions. It provides integrated contract and reverse logistics systems to customers from the healthcare and other industries. As part of its supply chain management (SCM) for industry, commerce and consumers, Vfw organizes and direct products and services. The company was founded in 1991 and is headquartered in Cologne, Germany.

Vodafone Deutschland GmbH engages in the provision of television, telecommunications, and multimedia services. It focuses on areas such as Internet, telephone, cable television, and wireless mobile networks. The company was founded on December 17, 2002 and is headquartered in Unterfoehring, Germany.

Kabel Deutschland Holding AG engages in the provision of cable network solutions. It offers internet, telephone, as well as cable and television services. The company was founded on February 19, 2010 and is headquartered in Unterfoehring, Germany.

ALTANA AG engages in the sale and distribution of chemical solutions for the coating; paint and plastic processor; printing and packaging; cosmetics; as well as electrical and electronics industries. Its products include additives; specialty coatings and adhesives; effect pigments; sealants and compounds; impregnating resins and varnishes; including testing and measuring instruments. The company was founded by Heinrich Byk in 1873 and is headquartered in Wesel, Germany.

HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds.